COVID-19 Respiratory InfectionNCT05697081
Oral Symptoms of COVID-19 Among Infected Medical Doctors
An observational study of COVID-19 Respiratory Infection, run by Beni-Suef University at 1 site in Egypt.
Trial summary
Oral symptoms of corona virus disease have been reported by many studies. The lack of direct contact between the dentist and the patient during the active disease presented an obstacle to build a strong body of evidence. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- COVID-19 Respiratory Infection
- What is being tested?
- Medical doctors infected with COVID-19
- How many people
- 312 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Feb 2019to 29 Dec 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: any medical doctors infected with COVID-19
Who may be able to join
- COVID-19 infection
- Medical doctors
Who cannot join
- none
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Oral Manifestations of COVID-19 Correlated to Medical History. A Survey on Infected Medical Doctors.
Oral symptoms of corona virus disease have been reported by many studies. The lack of direct contact between the dentist and the patient during the active disease presented an obstacle to build a strong body of evidence.
the aim of the study is to report the oral symptoms of COVID-19 and correlate the occurrence of these symptoms with various disease-related factors.
Read the detailed description
This is a cross-sectional web-based survey targeted Medical doctors infected with COVID-19. The survey questioned the diagnosis of the disease, the severity of the disease, the general symptoms, the oral symptoms along with drug and medical history.
The survey comprised a total of 3 main sections. The first section included demographic data and diagnostic method for COVID-19 infection. The second section included question about duration of the disease, the general manifestations of the disease, the previous medical history. History of smoking, severity of COVID-19 infection and history of hospitalization. Drug history and treatments for COVID-19. Presence of blood discrepancies during COVID-19 infection. The third section targeted detailed oral manifestations of the disease and questions about the oral hygiene and presence of previous oral lesions.
The questions about oral manifestations were designed based on a systematic search through the current literature, dated between 2019 and January 2021.
- Conditions
- COVID-19 Respiratory Infection
- Being tested
- Medical doctors infected with COVID-19
- Keywords
- COVID-19, Dysgeusia, Xerostomia
- Medical subject headings
- COVID-19, Dysgeusia, Xerostomia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Medical doctors infected with COVID-19Other
web-based survey
What is being measured
The primary outcome is the main question the study is designed to answer.
Occurrence of oral symptoms
Measured: 14 days of infection
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Jan 2023
- Study start1 Feb 2019
- Primary completion20 Dec 2022
- Study completion29 Dec 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for COVID-19 Respiratory InfectionStudies of the same condition, open and under way.
- More trials run by Beni-Suef UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 312 participants (actual)
Sponsor and investigators
- Lead sponsor
- Beni-Suef University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Eman Magdy Ahmed, Beni-Suef University
- Investigators
- Eman Magdy, Principal investigator, Lecturer
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05697081
- Sponsor's protocol ID
- FDBSUREC/10092020/ME
- Status last verified
- Jan 2023
- First submitted
- 20 Jan 2023
- Last updated
- 25 Jan 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: Survey
Study at a glance
From the registry record, last updated by the sponsor on 25 Jan 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Oral Manifestations of COVID-19 Correlated to Medical History. A Survey on Infected Medical Doctors.
- ClinicalTrials.gov ID
- NCT05697081
- Acronym / sponsor ID
- FDBSUREC/10092020/ME
- Conditions
- COVID-19 Respiratory Infection
- Keywords
- COVID-19, Dysgeusia, Xerostomia
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 312 participants (actual)
- Lead sponsor
- Beni-Suef UniversityUniversity, hospital or other
- Study start
- 1 Feb 2019 (actual)
- Primary completion
- 20 Dec 2022 (actual)
- Study completion
- 29 Dec 2022 (actual)
- First posted
- 25 Jan 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Oral symptoms of corona virus disease have been reported by many studies. The lack of direct contact between the dentist and the patient during the active disease presented an obstacle to build a strong body of evidence.
the aim of the study is to report the oral symptoms of COVID-19 and correlate the occurrence of these symptoms with various disease-related factors.
Detailed description
This is a cross-sectional web-based survey targeted Medical doctors infected with COVID-19. The survey questioned the diagnosis of the disease, the severity of the disease, the general symptoms, the oral symptoms along with drug and medical history.
The survey comprised a total of 3 main sections. The first section included demographic data and diagnostic method for COVID-19 infection. The second section included question about duration of the disease, the general manifestations of the disease, the previous medical history. History of smoking, severity of COVID-19 infection and history of hospitalization. Drug history and treatments for COVID-19. Presence of blood discrepancies during COVID-19 infection. The third section targeted detailed oral manifestations of the disease and questions about the oral hygiene and presence of previous oral lesions.
The questions about oral manifestations were designed based on a systematic search through the current literature, dated between 2019 and January 2021.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- any medical doctors infected with COVID-19
Key inclusion criteria (2 listed)
- COVID-19 infection
- Medical doctors
Key exclusion criteria (1 listed)
- none
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Medical doctors infected with COVID-19web-based survey | Other | – |
Primary outcome
Occurrence of oral symptoms
Time frame: 14 days of infection
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Jan 2023.
- Individual participant dataSharing planned: Undecided. Survey
Related trials for COVID-19 Respiratory Infection
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Active, not recruitingPhase 1
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
COVID-19
Recruiting
Home-Based Exercise Tele-Rehabilitation After COVID-19
Post SARS-CoV2 (COVID-19)
Not yet recruitingPhase 1
A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine
COVID -19
RecruitingObservational study
Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.
Pneumonia, Community-Acquired, COVID-19 Pneumonia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Eman Magdy principal investigator
Lecturer
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of COVID-19 Respiratory Infection, run by Beni-Suef University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Occurrence of oral symptoms (time frame: 14 days of infection). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jan 2023.